These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 2618685)

  • 1. [The dissolution rate and physical dispersion state of preparations of biphenyl dimethyl dicarboxylate (DDB)].
    Gu SJ; Gao WW; Qiao PX; Wang AG; Qiang ZY
    Yao Xue Xue Bao; 1989; 24(11):859-64. PubMed ID: 2618685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bioavailability studies on the preparations of biphenyl dimethyl dicarboxylate(DDB)].
    Gu SJ; Wang XL; Gao WW; Qiao PX; Wang AG; Qiang ZY; Song ZY
    Yao Xue Xue Bao; 1990; 25(3):215-9. PubMed ID: 2239337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative dissolution studies for mefenamic acid-polyethylene glycol solid dispersion systems and tablets.
    Owusu-Ababio G; Ebube NK; Reams R; Habib M
    Pharm Dev Technol; 1998 Aug; 3(3):405-12. PubMed ID: 9742561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug-polymer interactions.
    Karavas E; Georgarakis E; Sigalas MP; Avgoustakis K; Bikiaris D
    Eur J Pharm Biopharm; 2007 Jun; 66(3):334-47. PubMed ID: 17267194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissolution behaviour of nalidixic acid solid dispersions using water soluble dispersion carriers.
    Mallick S; Sahu A; Pal K
    Acta Pol Pharm; 2004; 61(1):21-30. PubMed ID: 15259854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of dissolution rate of hydrochlorothiazide via solid dispersion.
    Abd el-Fattah S; Boraie NA; Hassan HM
    Pharmazie; 1986 Nov; 41(11):790-3. PubMed ID: 3562513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
    Dhumal RS; Shimpi SL; Paradkar AR
    Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relating solubility data of parabens in liquid PEG 400 to the behaviour of PEG 4000-parabens solid dispersions.
    Unga J; Tajarobi F; Norder O; Frenning G; Larsson A
    Eur J Pharm Biopharm; 2009 Oct; 73(2):260-8. PubMed ID: 19508891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of a solid dispersion of felodipine using a solvent wetting method.
    Kim EJ; Chun MK; Jang JS; Lee IH; Lee KR; Choi HK
    Eur J Pharm Biopharm; 2006 Oct; 64(2):200-5. PubMed ID: 16750355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The application of solid dispersion technique in the preparation of therapeutic tablets. Part 1: Paracetamol, amylobarbitone, and caffeine tablets.
    El-Banna HM; Eshra AG; Hammouda Y
    Pharmazie; 1977; 32(8-9):511-5. PubMed ID: 145597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissolution rate of furosemide from polyethylene glycol solid dispersions.
    Ozdemir N; Ordu S
    Farmaco; 1997 Oct; 52(10):625-9. PubMed ID: 9507675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissolution, bioavailability and ulcerogenic studies on piroxicam-nicotinamide solid dispersion formulations.
    Verma MM; Kumar MT; Balasubramaniam J; Pandit JK
    Boll Chim Farm; 2003 Apr; 142(3):119-24. PubMed ID: 12806831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strongly enhanced dissolution rate of fenofibrate solid dispersion tablets by incorporation of superdisintegrants.
    Srinarong P; Faber JH; Visser MR; Hinrichs WL; Frijlink HW
    Eur J Pharm Biopharm; 2009 Sep; 73(1):154-61. PubMed ID: 19465121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam.
    Prabhu S; Ortega M; Ma C
    Int J Pharm; 2005 Sep; 301(1-2):209-16. PubMed ID: 16046087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of polyethylene glycol 6000 and mannitol on the in-vitro dissolution properties of nitrofurantoin by the dispersion technique.
    Akade MA; Agrawal DK; Lauwo JA
    Pharmazie; 1986 Dec; 41(12):849-51. PubMed ID: 3106994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers.
    Ahuja N; Katare OP; Singh B
    Eur J Pharm Biopharm; 2007 Jan; 65(1):26-38. PubMed ID: 16962750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer-surfactant combinations using solubility parameters and testing the processability.
    Ghebremeskel AN; Vemavarapu C; Lodaya M
    Int J Pharm; 2007 Jan; 328(2):119-29. PubMed ID: 16968659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [X-ray diffraction studies on tolbutamide solid dispersion].
    Ma X; Rong SK; Wu QQ; Zhou GX
    Yao Xue Xue Bao; 1992; 27(2):144-9. PubMed ID: 1414371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraorally fast-dissolving particles of a poorly soluble drug: preparation and in vitro characterization.
    Laitinen R; Suihko E; Toukola K; Björkqvist M; Riikonen J; Lehto VP; Järvinen K; Ketolainen J
    Eur J Pharm Biopharm; 2009 Feb; 71(2):271-81. PubMed ID: 18824096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of solid dispersion technique combination on dissolution of tanshinone IIA].
    Yuan J; Mao S; Shen Q; Hou S; He Y
    Zhongguo Zhong Yao Za Zhi; 2009 Mar; 34(6):685-9. PubMed ID: 19624004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.